Raloxifene (Evista) — Research Compounds Library | RetatrutideCompare

Selective estrogen-receptor modulator. FDA-approved for postmenopausal osteoporosis treatment / prevention and reduction of invasive breast-cancer risk in high-risk postmenopausal women.